Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Invest New Drugs. 2009 Oct 21;29(2):347–351. doi: 10.1007/s10637-009-9338-1

Table 1.

Patients Demographics

Clinical Parameter N=15
Median Age (range)    48 (30–80)
SWOG performance status
0  7
1  7
2  1
Race
White 13
African-American   2
Receptor status
ER or PR-positive   7
ER/PR-negative   5
ER/PR unknown   3
Prior therapy
Adjuvant chemotherapy 13
Metastatic 13
Radiation therapy  8
Site of metastatic disease
Skeleton 10
Liver   7
Lung 10
Lymph nodes   8

Abbreviations: Estrogen receptor (ER); Progesterone receptor (PR);